Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Felix Meincke"'
Autor:
Jens Erik Nielsen-Kudsk, Timothy R. Betts, Kasper Korsholm, Gilles Rioufol, Thomas Schmitz, Sven Möbius-Winkler, Boris Schmidt, Jean Benoit Thambo, Blanca Trejo-Velasco, Marcus Sandri, Felix Meincke, Patrizio Mazzone, Marek Grygier, Ignacio Cruz-González
Publikováno v:
Cruz-Gonzalez, I, Korsholm, K, Trejo-Velasco, B, Thambo, J B, Mazzone, P, Rioufol, G, Grygier, M, Möbius-Winkler, S, Betts, T, Meincke, F, Sandri, M, Schmidt, B, Schmitz, T & Nielsen-Kudsk, J E 2020, ' Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device ', JACC. Cardiovascular interventions, vol. 13, no. 23, pp. 2732-2741 . https://doi.org/10.1016/j.jcin.2020.06.056
JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, 2020, 13 (23), pp.2732-2741. ⟨10.1016/j.jcin.2020.06.056⟩
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2020, 13 (23), pp.2732-2741. ⟨10.1016/j.jcin.2020.06.056⟩
JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, 2020, 13 (23), pp.2732-2741. ⟨10.1016/j.jcin.2020.06.056⟩
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2020, 13 (23), pp.2732-2741. ⟨10.1016/j.jcin.2020.06.056⟩
OBJECTIVES: This study sought to report early experience with the new-generation Watchman FLX device (Boston Scientific, Marlborough, Massachusetts).BACKGROUND: The new-generation Watchman FLX features a reduced height, improved anchoring and fabric
Autor:
Alexey Vladimir Protopopov, Marek Grygier, following investigators, David P. Foley, Elisa Vireca, Timothy R. Betts, Horst Sievert, Kenneth M. Stein, Boris Schmidt, Felix Meincke, Hueseyin Ince, Tommaso Gori, Stephan Kische, Patrizio Mazzone, Evgeny Pokushalov, Lucas V.A. Boersma, Tom De Potter, Thomas Schmitz, Martin Bergmann
Publikováno v:
Circulation-arrhythmia and electrophysiology, 12(4):e006841. Lippincott Williams & Wilkins
Background: Left atrial appendage occlusion with WATCHMAN has emerged as viable alternative to vitamin K antagonists in randomized controlled trials. Evaluating real-life clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86447938275a75dc609b7332a6b59140
https://pure.eur.nl/en/publications/df21210f-d8e2-4ba9-8c82-9d876384952b
https://pure.eur.nl/en/publications/df21210f-d8e2-4ba9-8c82-9d876384952b
Publikováno v:
EuroIntervention. 9:463-468
Aims: The WATCHMAN ® device was proven non-inferior to oral anticoagulation (OAT). However, periprocedural risks and uncertainty regarding patients with absolute contraindication for OAT limit the overall utilisation of this approach. We investigate
Publikováno v:
Journal of the American College of Cardiology. 63(12)
Autor:
Ulrich Schäfer, Karl-Heinz Kuck, Jasper von Wedel, Felix Meincke, Felix Kreidel, Martin Bergmann
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 10(10)